New updates have been reported about WHOOP.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
WHOOP has raised $575 million in a Series G round that values the health and performance wearable company at $10.1 billion, nearly tripling its prior $3.6 billion mark and bringing total funding to roughly $900 million. The round, led by Collaborative Fund, adds major sovereign wealth funds, large institutions, and prominent athlete-investors to WHOOP’s cap table, positioning the company as a scaled global player in connected health and subscription-based performance analytics.
A key strategic development is the participation of Abbott, which CEO Will Ahmed describes as the start of a broader push into health and medical capabilities, with more detailed initiatives yet to be disclosed. Ahmed reports WHOOP exited last year at a $1.1 billion bookings run rate, up 103% year over year, emphasizing bookings as the core metric for understanding the company’s cash dynamics across hardware distribution, inventory management, and recurring subscription revenue.
Management plans to deploy the new capital into accelerated hiring, increased marketing and brand investment, expanded R&D, and faster international growth, reinforcing WHOOP’s shift from niche performance tool to mainstream health platform. While Ahmed notes the company is undertaking “no-regrets” preparation to operate as a public company, he stopped short of committing to an IPO timeline, even as competitors explore listings and investor interest in consumer health tech remains high.
The participation of global sovereign funds and elite athletes underscores confidence in WHOOP’s long-term positioning at the intersection of consumer wearables, AI-driven insights, and clinical-grade health partnerships. With a substantially larger balance sheet and strategic healthcare alignment, WHOOP now has extended runway to scale its subscription ecosystem, deepen medical integrations, and potentially enter public markets from a position of strength.